Skip to main content

Remote Job Finders (RJF)

Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site

Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.

Gilead sets blockbuster bar for Yeztugo’s first full year on the market

With initial patients coming back for their second dose of Gilead’s twice-yearly PrEP injection, the pharma thinks the shot will hit $1 billion in sales this year, serving as “a cornerstone in Gilead’s revenue growth story.”
Scroll to top